GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A

GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A

SSSE:600771
12.20
CNY
+0.07
(+0.58%)
0.13EPS
109.23P/E
6.93BMarket Cap
Apr 23Next Earn

Total Valuation

CNY

As of September 30, 2026, GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A carries a market capitalization of 6.93B, placing it among publicly traded companies globally. Its enterprise value stands at 6.51B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap6.93B
Enterprise Value6.51B

Important Dates

GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A's next confirmed earnings release is scheduled for April 23, 2027.

Earnings Date4/23/2027

Share Statistics

As of September 30, 2026, GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A has 489.49M shares outstanding.

Shares Outstanding489.49M

Valuation Ratios

As of September 30, 2026, GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A trades at a trailing price-to-earnings ratio of 109.23. The price-to-sales ratio is 5.26, and the price-to-book ratio stands at 4.17.

PE Ratio109.23
PS Ratio5.26
PB Ratio4.17
P/TBV Ratio4.39

Enterprise Valuation

As of September 30, 2026, GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A trades at an EV/EBITDA multiple of 86.41 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 4.97 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 86.41 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 6.51B versus a market cap of 6.93B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales4.97
EV / EBITDA86.41
EV / EBIT86.41

Financial Position

As of September 30, 2026, GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A maintains a current ratio of 2.36, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.46, indicating elevated leverage, while an interest coverage ratio of 38.52 demonstrates strong ability to service its debt obligations.

Current Ratio2.36
Quick Ratio0.71
Debt / Equity2.46
Debt / EBITDA0.55
Interest Coverage38.52

Financial Efficiency

CNY

Over the twelve months ended September 30, 2026, GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A posted a return on equity (ROE) of 3.82, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 4.02 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 2.61, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 3.67, useful for judging operating efficiency across full business cycles. The company generates approximately 752,164.73 in revenue per employee across its workforce of 1,744.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.64 indicates how many times GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)3.82
Return on Assets (ROA)2.61
Return on Invested Capital (ROIC)4.02
Return on Capital Employed (ROCE)3.67
Revenue Per Employee752,164.73
Employee Count1,744.00
Inventory Turnover0.64

Taxes

CNY

Over the twelve months ended September 30, 2026, GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A recorded 10.50M in income tax expense. That works out to an effective tax rate of 13.97, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 75.16M, leaving 63.22M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax10.50M
Effective Tax Rate13.97

Stock Price Statistics

CNY

As of the close on November 17, 2026, GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A's stock has declined approximately 38.13% over the past 52 weeks. The 50-day moving average sits at 13.46, while the 200-day moving average is 15.19.

52-Week Price Change-38.13%
50-Day Moving Average13.46
200-Day Moving Average15.19

Income Statement

CNY

Over the twelve months ended September 30, 2026, GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A generated 1.31B in revenue and converted that into 63.22M in net income, yielding earnings per share of 0.13. EBITDA reached 75.39M, while operating income came in at 102.03M.

Revenue1.31B
Gross Profit871.16M
Operating Income102.03M
Pretax Income75.16M
Net Income63.22M
EBITDA75.39M
EBIT75.39M
Earnings Per Share (EPS)0.13

Balance Sheet

CNY

As of September 30, 2026, GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A holds 472.81M in cash and equivalents against 41.38M in total debt, resulting in a net debt position of -317.22M. Total book value stands at 1.66B, with working capital of 907.35M providing operational flexibility.

Cash & Cash Equivalents472.81M
Total Debt41.38M
Net Debt-317.22M
Equity (Book Value)1.66B
Book Value Per Share3.39
Working Capital907.35M

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-7.60M

Margins

Over the twelve months ended September 30, 2026, GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A posted a gross margin of 66.41, reflecting its pricing power and cost economics. The operating margin of 7.78 and net profit margin of 4.82 provide insight into operational efficiency.

Gross Margin66.41
Operating Margin7.78
Pretax Margin5.73
Profit Margin4.82
EBITDA Margin5.75

Dividends & Yields

These figures cover the twelve months ended September 30, 2026. Total shareholder yield reaches 0.54, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A shareholders.

Shareholder Yield0.54

Stock Splits

GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A's most recent stock split took place on May 30, 2019 with a 5:7 split ratio.

Last Split Date5/30/2019
Split Ratio5:7

Scores

As of September 30, 2026, GuangYuYuan Chinese Herbal Medicine Co., Ltd. Class A has an Altman Z-Score of 7.19, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score7.19